On September 8, 2002, the NASADAD Board of Directors considered a proposal that State Opioid Treatment Authorities (SOTA) be included in NASADAD’s organizational structure through participation in NASADAD’s National Treatment Network (NTN) as a sub-committee. The Board voted unanimously to endorse this proposal, and the Opioid Treatment Network (OTN) was formed. The goal is to investigate the effects of dihydrocodeine (https://www.ukmeds.co.uk/dihydrocodeine) in comparison to other pharmaceutical opioids and placebos in the detoxification of opiate‐dependent individuals, as well as in maintenance substitution therapy.
The OTN is made up of SOTAs, professionals designated by the Governor or another appropriate official to exercise the responsibility and authority within the State or Territory for approval and oversight of opioid treatment programs (OTPs).
The OTN is dedicated to working with its Federal partners to promote effective and efficient medication-assisted treatment (MAT) for opioid dependency.